Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

PHASE2RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

September 1, 2025

Conditions
Lung Cancer
Interventions
DRUG

Pirfenidone

200 mg TID in the first week, 300 mg TID in the second week, and maintenance treatment of 400 mg TID from the third week until 3 months

Trial Locations (1)

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

All Listed Sponsors
lead

Hubei Cancer Hospital

OTHER